184 related articles for article (PubMed ID: 10069408)
21. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
[TBL] [Abstract][Full Text] [Related]
22. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.
Huerta C; Johansson S; Wallander MA; García Rodríguez LA
Arch Intern Med; 2007 May; 167(9):935-43. PubMed ID: 17502535
[TBL] [Abstract][Full Text] [Related]
24. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
Gomes MP; Deitcher SR
Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
[TBL] [Abstract][Full Text] [Related]
25. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
[TBL] [Abstract][Full Text] [Related]
26. [Pregnancy, contraception and HRT and venous thromboembolism].
Conard J; Gompel A
Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
[TBL] [Abstract][Full Text] [Related]
27. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M; Scarabin PY
Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
[TBL] [Abstract][Full Text] [Related]
28. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
Scarabin PY; Oger E; Plu-Bureau G;
Lancet; 2003 Aug; 362(9382):428-32. PubMed ID: 12927428
[TBL] [Abstract][Full Text] [Related]
29. Venous thrombo-embolism and hormone replacement therapy.
Whitehead M; Godfree V
Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):587-99. PubMed ID: 9488793
[TBL] [Abstract][Full Text] [Related]
30. [Hormone replacement therapy and venous thromboembolism].
Trillot N; Susen S; Jude B
Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
[TBL] [Abstract][Full Text] [Related]
31. Hormone replacement therapy in women with history of thrombosis or a thrombophilia.
Morris G; Talaulikar V
Post Reprod Health; 2023 Mar; 29(1):33-41. PubMed ID: 36573625
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
33. Factor V Leiden and venous thromboembolism: risk associated with hormone replacement therapy.
Park BD; Lookinland S; Beckstrand RL; Chasson S
J Am Acad Nurse Pract; 2003 Oct; 15(10):458-66. PubMed ID: 14606135
[TBL] [Abstract][Full Text] [Related]
34. The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial.
Høibraaten E; Qvigstad E; Andersen TO; Mowinckel MC; Sandset PM
Thromb Haemost; 2001 May; 85(5):775-81. PubMed ID: 11372667
[TBL] [Abstract][Full Text] [Related]
35. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
36. Venous thromboembolism in relation to oral contraceptive use.
Helmrich SP; Rosenberg L; Kaufman DW; Strom B; Shapiro S
Obstet Gynecol; 1987 Jan; 69(1):91-5. PubMed ID: 3796927
[TBL] [Abstract][Full Text] [Related]
37. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.
Varas-Lorenzo C; García-Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Perez-Gutthann S
Am J Epidemiol; 1998 Feb; 147(4):387-90. PubMed ID: 9508106
[TBL] [Abstract][Full Text] [Related]
38. Incidence of symptomatic venous thromboembolism after elective knee arthroscopy.
Maletis GB; Inacio MC; Reynolds S; Funahashi TT
J Bone Joint Surg Am; 2012 Apr; 94(8):714-20. PubMed ID: 22517387
[TBL] [Abstract][Full Text] [Related]
39. [Oral contraception and hormone replacement therapy: management of their thromboembolic risk in the perioperative period].
Chalhoub V; Edelman P; Staiti G; Benhamou D
Ann Fr Anesth Reanim; 2008 May; 27(5):405-15. PubMed ID: 18472389
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
